COVID-19: A MESSAGE TO OUR CUSTOMERS 

The Brigham and Dana-Farber Board Review in Hematology and Oncology

Brigham and Women’s Hospital Board Review

This comprehensive CME program offers an in-depth, case-base review of the clinical essentials in hematology and oncology. Ideal for MOC.

If your primary viewing mode will be on a computer or tablet, we recommend the Online Video package. In addition to online access, you will receive a USB with MP4 files. Use the USB to watch offline or import into iTunes and other media players and then synch to your mobile device, laptop or desktop. Plus you save $130 including standard shipping charges vs the DVD package.

    Video
  • Audio MP3s
1795.0000
SKU: 362

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. In this CME program, expert speakers address relevant topics in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Apply new knowledge to the ABIM certification/recertification hematology and oncology examinations

Discover New Guidelines

This learn-at-your-own-pace course in hematology and oncology provides a maximum of 44 AMA PRA Category 1 Creditsand 44 ABIM MOC points. Available online or via audio MP3 CDs, it provides access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

Quick Facts

Provider: Brigham and Women’s Hospital

Course Directors:
Maureen M. Achebe, MD, MPH
Brigham and Women's Hospital

Nancy Berliner, MD
Brigham and Women's Hospital

Wendy Y. Chen, MD
Brigham and Women’s Hospital

Course Director, The Brigham Board Review Distance Learning Series:
Ajay K. Singh, MBBS, FRCP (UK), MBA
Senior Associate Dean for Postgraduate
Medical Education
Director, Master in Medical Sciences in
Clinical Investigation (MMSCI) Program
Harvard Medical School
Director, Office of Postgraduate
Medical Education
Department of Medicine
Brigham and Women's Hospital

Credits: Earn a maximum of 44 AMA PRA Category 1 Credits ™ and 44 ABIM MOC points

  • Molecular Genetics of Cancer - Nikhil Wagle, MD
  • Advances in Cancer Drug Development - Geoffrey I. Shapiro, MD, PhD
  • Infections in Cancer Patients - Lindsey Baden, MD
  • Symptom Management in Patients with Cancer - Andrew J. Lawton, MD
  • Communication: The Key to Excellence in End-of-Life Care - Rachelle E. Bernacki, MD
  • Biology of Hematopoietic Stem Cell Transplantation - Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes - Benjamin L. Ebert, MD, PhD
  • Acute Leukemias - Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome - David P. Steensma, MD
  • Chronic Myelogenous Leukemia - Marlise R. Luskin, MD
  • Myeloproliferative Syndromes - Ann M. Mullally, MD
  • Multiple Myeloma - Kenneth C. Anderson, MD
  • Waldenstrom Macroglobulemia and Amyloidosis - Jorge J. Castillo, MD
  • Low Grade Lymphomas - Caron A. Jacobson, MD
  • High Grade Lymphomas - Eric D. Jacobsen, MD
  • Hodgkin's Lymphoma - Jennifer L. Crombie, MD
  • Diagnosis and Treatment of CLL and Related B Cell Malignancies - Matthew S. Davids, MD
  • Head and Neck Cancer - Robert I. Haddad, MD
  • Natural History, Screening, Surgery and Small Cell Lung Cancer - Bruce E. Johnson, MD
  • Non Small Cell Lung Cancer - Mark Awad, MD, PhD
  • Mesothelioma and Thymoma - David M. Jackman, MD
  • Thyroid Cancer - Jochen Lorch, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors - Jennifer Ang Chan, MD
  • Esophageal and Gastric Cancer - Peter C. Enzinger, MD
  • Pancreatic and Hepatobiliary Cancer - Brian M. Wolpin, MD
  • Anal Cancers - Robert J. Mayer, MD
  • Colorectal Cancers - Robert J. Mayer, MD
  • Gastrointestinal Cancer: Genetic Syndromes - Matthew Yurgelun, MD
  • Germ Cell Tumor: Maximizing Cure While Minimizing the Burden of Therapy - Mark M. Pomerantz, MD
  • Renal and Bladder Cancer - Guru P. Sonpavde, MBBS
  • Prostate Cancer Part I: Overview and Management of Localized Disease - Atish D. Choudhury, MD, PhD
  • Prostate Cancer Part II: Management of Disseminated Prostate Cancer - Atish D. Choudhury, MD, PhD
  • Melanoma - F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) - George D. Demetri, MD
  • Ovarian Cancer - Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer - Panagiotis A. Konstantinopoulos, MD, PhD
  • Neuro-oncology - David A. Reardon, MD
  • Breast Cancer: Risk Factors, Genetics, Screening, and Prevention - Judy E. Garber, MD, MPH
  • Multimodality Therapy for Early Stage Breast Cancer: Part 1 - Surgery and Radiation - Harold J. Burstein, MD, PhD
  • Multimodality Therapy for Early Stage Breast Cancer: Part 2 - Systemic Therapy - Harold J. Burstein, MD, PhD
  • Management of Metastatic Breast Cancer - Erica Mayer, MD, MPH
  • Breast Cancer Survivorship - Ann H. Partridge, MD, MPH
  • Hematopoiesis and Cytokines - David T. Scadden, MD
  • Acquired Bone Marrow Failure - Julie-Aurore Losman, MD, PhD
  • Congenital Bone Marrow Failure - Akiko Shimamura, MD, PhD
  • Hemophagocytic Syndromes and Related Immunodeficiencies - Barbara A. Degar, MD
  • Anemia: An Overview - Ronald P. McCaffrey, MD
  • Iron Deficiency and Iron Overload - Mark D. Fleming, MD, PhD
  • Immune Hemolytic Anemia - Richard M. Kaufman, MD
  • Non-immune Hemolytic Anemia - David E. Golan, PhD, MD
  • Sickle Cell Disease - Maureen M. Achebe, MD, MPH
  • Thalassemia and Other Hemoglobinopathies - Matthew M. Heeney, MD
  • Disorders of Neutrophils - Nancy Berliner, MD
  • Acquired Thrombocytopenias - Elisabeth M. Battinelli, MD, PhD
  • Hemophilia - Aric D. Parnes, MD
  • Von Willebrand Disease and Congenital Platelet Disorders - Nathan T. Connell, MD, MPH
  • Congenital and Acquired Thrombophilia - Kenneth A. Bauer, MD
  • Use of Direct Oral Anticoagulants in Clinical Practice - Jean M. Connors, MD
  • Transfusion Medicine for the Clinician - Walter H. Dzik, MD

Course Directors

Maureen M. Achebe, MD, MPH

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Nancy Berliner, MD

  • Professor of Medicine
  • Harvard Medical School
  • Chief, Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Wendy Y. Chen, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Course Director, The Brigham Board Review Distance Learning Series

Ajay K. Singh, MBBS, FRCP(UK), MBA

  • Senior Associate Dean for Postgraduate Medical Education
  • Director, Master in Medical Sciences in Clinical Investigation (MMSCI) Program
  • Harvard Medical School
  • Director, Office of Postgraduate Medical Education
  • Department of Medicine
  • Brigham and Women's Hospital

Faculty

Kenneth C. Anderson, MD

  • Kraft Family Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Mark Awad, MD, PhD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Lindsey Baden, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Division of Infectious Diseases
  • Department of Medicine
  • Brigham and Women’s Hospital

Elisabeth M. Battinelli, MD, PhD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Kenneth A. Bauer, MD

  • Professor of Medicine
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Beth Israel Deaconess Medical Center

Rachelle E. Bernacki, MD, MS, FAAHPM, AGSF

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Harold J. Burstein, MD, PhD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Jorge J. Castillo, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Jennifer Ang Chan, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Atish D. Choudhury, MD, PhD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Nathan T. Connell, MD, MPH

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Jean M. Connors, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Jennifer L. Crombie, MD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Matthew S. Davids, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Daniel J. DeAngelo, MD, PhD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Barbara A. Degar, MD

  • Assistant Professor of Pediatrics
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Cancer and Blood Disorders Center
  • Boston Children’s Hospital

George D. Demetri, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Walter H. Dzik, MD

  • Associate Professor of Pathology
  • Harvard Medical School
  • Department of Pathology
  • Massachusetts General Hospital

Benjamin L. Ebert, MD, PhD

  • George P. Canellos, MD, and Jean S. Canellos Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Peter C. Enzinger, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Mark D. Fleming, MD, PhD

  • S. Burt Wolbach Professor of Pathology
  • Harvard Medical School
  • Department of Pathology
  • Boston Children’s Hospital

Judy E. Garber, MD, MPH

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David E. Golan, PhD, MD

  • Professor of Biological Chemistry and Molecular Pharmacology
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Robert I. Haddad, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Matthew M. Heeney, MD

  • Associate Professor of Pediatrics
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Division of Hematology
  • Department of Medicine
  • Boston Children’s Hospital

F. Stephen Hodi, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David M. Jackman, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

 

Eric D. Jacobsen, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Caron A. Jacobson, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Bruce E. Johnson, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Richard M. Kaufman, MD

  • Associate Professor of Pathology
  • Harvard Medical School
  • Department of Pathology
  • Brigham and Women's Hospital

Panagiotis A. Konstantinopoulos, MD, PhD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Andrew J. Lawton, MD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Jochen Lorch, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Julie-Aurore Losman, MD, PhD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Marlise R. Luskin, MD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Ursula A. Matulonis, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Erica Mayer, MD, MPH

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Robert J. Mayer, MD

  • Stephen B. Kay Family Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Ronald P. McCaffrey, MD

  • Professor of Medicine – Part-Time
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Ann M. Mullally, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Aric D. Parnes, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Brigham and Women's Hospital

Ann H. Partridge, MD, MPH

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Mark M. Pomerantz, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David A. Reardon, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David T. Scadden, MD

  • Professor of Stem Cell and Regenerative Biology
  • Harvard Medical School
  • Division of Hematology
  • Department of Medicine
  • Massachusetts General Hospital

Geoffrey I. Shapiro, MD, PhD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Akiko Shimamura, MD, PhD

  • Professor of Pediatrics
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Cancer and Blood Disorders Center
  • Boston Children’s Hospital

Robert J. Soiffer, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Guru P. Sonpavde, MBBS

  • Member of the Faculty of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David P. Steensma, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Nikhil Wagle, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Brian M. Wolpin, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Matthew Yurgelun, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Accreditation

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing designates this enduring material for a maximum of 44 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 44 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion informaion to ACCME for the purpose of granting ABIM MOC credit.

Date of Original Release: April 15, 2020
Termination Date: April 15, 2023

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Apply current/recommended Hematology and Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
  • Identify/apply current therapeutic options for specific Hematologic and Oncologic disorders
  • Review and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
  • Demonstrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
  • Apply knowledge gained to the ABIM Certification/Recertification Hematology and Oncology examinations

Intended Audience

The activity was planned for fellows/trainees, practicing Hematology and Oncology specialists (MDs), and other professional affiliates (internists with an interest in Hematology and Oncology) who are preparing to take ABIM Board Review or Recertification Examinations, or who seek CME activities to improve patient care in the areas of Hematology and Oncology Medicine.